Novo Nordisk falls heavily on the stock exchange on Friday after Donald Trump made new statements about slimming drug prices. (Archive photo). Photo: Dado Ruvic/Reuters
Novo Nordisk hit on stock market after new Trump remarks
Novo Nordisk’s shares dropped about five percent on Friday. The decline follows comments from U.S. President Donald Trump about reducing prices for slimming medications. Trump specifically mentioned Novo’s diabetes drug, Ozempic, stating, “It will be much cheaper.” Despite being an old...
Get full access to Danish News in English
Gain exclusive access to daily news updates in English pertaining to Denmark with a Ritzau News subscription.
Already a subscriber?